Skip to main content
Premium Trial:

Request an Annual Quote

FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of Complete Genomics, the Mountain View, Calif-based sequencing services firm said in a document filed with the US Securities and Exchange Commission on Friday.

As a result, the waiting period applicable under the Hart-Scott-Rodino Antitrust Improvement Act of 1976 has been extended beyond the original date of 11:59 PM EDT Oct. 31. The waiting period will now expire at 11:59 ET on the 10th day after Complete Genomics and BGI comply with FTC's request.

Last month, BGI extended its tender offer for Complete Genomics to midnight Nov. 21. It originally was to expire midnight, Oct. 23.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.